Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Roivant Sciences Ltd (ROIV)
Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,251,112
  • Shares Outstanding, K 805,846
  • Annual Sales, $ 61,280 K
  • Annual Income, $ -1,009 M
  • 60-Month Beta 1.37
  • Price/Sales 154.78
  • Price/Cash Flow N/A
  • Price/Book 1.40
Trade ROIV with:

Options Overview Details

View History
  • Implied Volatility 54.53% ( +8.22%)
  • Historical Volatility 26.24%
  • IV Percentile 22%
  • IV Rank 22.11%
  • IV High 102.72% on 07/05/23
  • IV Low 40.85% on 04/21/23
  • Put/Call Vol Ratio 0.09
  • Today's Volume 2,318
  • Volume Avg (30-Day) 2,258
  • Put/Call OI Ratio 0.99
  • Today's Open Interest 54,100
  • Open Int (30-Day) 50,852

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.31
  • Number of Estimates 3
  • High Estimate -0.20
  • Low Estimate -0.39
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -55.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.97 +15.15%
on 02/06/24
12.00 -4.33%
on 03/04/24
+1.46 (+14.57%)
since 02/05/24
3-Month
9.48 +21.10%
on 12/08/23
12.00 -4.33%
on 03/04/24
+1.66 (+16.90%)
since 12/05/23
52-Week
6.59 +74.34%
on 03/23/23
13.24 -13.29%
on 09/28/23
+3.43 (+42.61%)
since 03/03/23

Most Recent Stories

More News
Roche's Bold Move into Obesity Treatment with $2.7B Carmot Therapeutics Takeover

Swiss pharmaceutical giant Roche (ROG) has marked a significant strategic shift by acquiring Carmot Therapeutics (CRMO), an obesity drug developer, for an upfront payment of $2.7 billion. This move positions...

ROG : 110.71 (-1.01%)
LLY : 785.40 (-0.87%)
AZN : 64.97 (+0.28%)
PFE : 25.96 (+0.27%)
ROIV : 11.48 (unch)
Is Roivant Sciences (ROIV) the Right Biotech Stock for Your Portfolio?

While Roivant Sciences (ROIV) has been seeing stable revenue growth, its bottom line is in the red. So, will it be worth owning ROIV now? Let’s discuss some of its key financial metrics to gauge its...

INCY : 59.72 (unch)
OTSKY : 20.0300 (-0.64%)
ROIV : 11.48 (unch)
VRTX : 426.18 (+0.51%)
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy

The market's dour reaction to Roivant Sciences' latest deal doesn't add up.

RHHBY : 32.8800 (-0.60%)
XBI : 100.25 (-0.48%)
ROIV : 11.48 (unch)
PFE : 25.96 (+0.27%)
3 No-Brainer Growth Stocks to Buy in October

These three top mid-cap stocks could be poised for a long-tailed growth spurt.

CRSP : 80.22 (-1.86%)
DKNG : 44.46 (-0.91%)
ROIV : 11.48 (unch)
Why Immunovant Stock Is Bolting Higher Today

The company may have best-in-class autoimmune disease therapy under its roof.

ARGX : 390.32 (-0.81%)
JNJ : 160.24 (+0.25%)
IMVT : 34.74 (-1.59%)
ROIV : 11.48 (unch)
Why Shares of Immunovant Are Soaring on Tuesday

Immunovant sees strong potential for an autoimmune disorder therapy.

ROIV : 11.48 (unch)
RJF : 120.87 (+0.67%)
IMVT : 34.74 (-1.59%)
These 2 Biotech Stocks Are Bucking a Down Market Tuesday

Stock index futures pointed to a lower open on Wall Street Tuesday morning.

IMVT : 34.74 (-1.59%)
ROIV : 11.48 (unch)
2 Supercharged Growth Stocks Billionaires Can't Stop Buying

A top hedge fund has been steadily buying these two growth stocks in 2023.

PFE : 25.96 (+0.27%)
ACAD : 24.10 (+1.47%)
ROIV : 11.48 (unch)
Housing, Retail Figures Due Next Week

Housing, Retail Figures Due Next Week Monday U.S. Featured Earnings Roivant (NASDAQ: ...

BLX.TO : 28.99 (-1.13%)
CJT.TO : 109.08 (-2.82%)
PBH.TO : 89.75 (-0.50%)
ROIV : 11.48 (unch)
MNDY : 228.53 (-0.70%)
RETA : 172.36 (+0.02%)
HD : 380.00 (-0.10%)
A : 143.95 (+0.76%)
SE : 54.50 (+1.11%)
CSCO : 49.03 (-0.20%)
TJX : 98.20 (+0.27%)
SNPS : 594.32 (+0.50%)
2 Magnificient Growth Stocks I'm Buying in August

These biotech stocks could markedly outperform the broader market.

ROIV : 11.48 (unch)
VKTX : 90.75 (-0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 12.43
2nd Resistance Point 12.21
1st Resistance Point 11.85
Last Price 11.48
1st Support Level 11.27
2nd Support Level 11.05
3rd Support Level 10.69

See More

52-Week High 13.24
Last Price 11.48
Fibonacci 61.8% 10.70
Fibonacci 50% 9.91
Fibonacci 38.2% 9.13
52-Week Low 6.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar